The primary aim of this study is to to retrospectively evaluate the efficacy of the MWCC Jump Start (Medifast's 5 \& 1) Plan on the following indices: weight loss, anthropometric changes, and reduction in common markers of coronary heart disease.
Portion-controlled meal replacements by themselves have been shown to be an effective weight control strategy in overweight and obese individuals. The addition of medical supervision has been shown to result in greater weight loss than meal replacements alone. MWCC provides this added support through individual weekly counseling sessions. Thus, the investigators plan to retrospectively evaluate the efficacy of the MWCC Jump Start (Medifast's 5 \& 1) Plan on the following indices: weight loss, anthropometric changes, and reduction in common markers of coronary heart disease.
Study Type
OBSERVATIONAL
Enrollment
446
Changes in weight
Weight loss (in pounds and percent weight loss) at weeks 4, 12, 24 and at final weight loss visit (average of 19.6 weeks).
Time frame: weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)
Changes in body composition
changes in lean muscle mass, body fat mass, and body fat percent at weeks 4, 12, 24, and final weight loss visit(average of 19.6 weeks).
Time frame: weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)
Compliance
Compliance is measured by client attendance at weekly visits, consumption of meal replacements and dietary supplements, ketone testing, and completion of food journals
Time frame: weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)
Retention rates
Retention of clients at specified time points (weeks 4, 12, 24 and final weight loss visit) and during the transition and weight maintenance phases of the MWCC weight management program
Time frame: weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)
Goal weight achievement
The percent of clients that achieve thier goal weight by their final weight loss visit(average of 19.6 weeks)
Time frame: Final weight loss visit (average of 19.6 weeks)
Changes in abdominal circumference (inches)
Time frame: weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)
Maintenance of weight loss
Time frame: Following transition (up to 12 weeks) and maintenance (up to 52 weeks) phases of the program
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Changes in cardiovascular risk factors
Improvements in diastolic and systolic blood pressure and pulse at weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks).
Time frame: weeks 4, 12, 24 and final weight loss visit (average of 19.6 weeks)